Frequent detection of T cells with mutations of the hypoxanthine-guanine phosphoribosyl transferase gene in patients with paroxysmal nocturnal hemoglobinuria

Blood

Volumn 99, Issue 1, 2002, Pages 24-29

  Horikawa, Kentaro ^a   Kawaguchi, Tatsuya ^a   Ishihara, Sonoko ^a   Nagakura, Shoichi ^a   Hidaka, Michihiro ^a   Kagimoto, Tadashi ^a   Mitsuya, Hiroaki ^a   Nakakuma, Hideki ^b  

^a Kumamoto University School of Medicine ^*

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESSENGER RNA; METENOLONE ACETATE; PREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HEMOGLOBINURIA; HUMAN; HUMAN CELL; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0036095964     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.24     Document Type: Article

References (43)

1. Evolution of clinical understanding: Paroxysmal nocturnal hemoglobinuria as a paradigm
2. Natural history of paroxysmal nocturnal hemoglobinuria
3. The molecular basis of paroxysmal nocturnal hemoglobinuria
4. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH)
5. Paroxysmal nocturnal hemoglobinuria (PNH) I, II, and III
6. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay
7. Diagnosis of paroxysmal nocturnal hemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF
8. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients
9. Impaired glycosylation of glycosyl-phosphatidylinositol-anchor synthesis in paroxysmal nocturnal hemoglobinuria leucocytes
10. Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria
11. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria
12. Somatic mutations in paroxysmal nocturnal hemoglobinuria: A blessing in disguise?
13. Increased frequency of somatic mutations at glycophorin A loci in patients with aplastic anaemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria
14. Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria
15. Rarity of microsatellite alterations in patients with paroxysmal nocturnal hemoglobinuria
16. Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma
17. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosyl-phosphatidylinositol-anchored protein-deficient clone
18. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals
19. Somatic mutations and cellular selection in paroxysmal nocturnal hemoglobinuria
20. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria
21. A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones
22. Paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes
23. Leukemia arising out of paroxysmal nocturnal hemoglobinuria
24. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia
25. Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood
26. Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed incyclophosphamide production
27. In vivo somatic mutations in humans: Measurement and analysis
28. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations
29. Analysis of mutations occurring at the human hprt locus
30. An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: A comparison of four datasets
31. Conditional mutator phenotypes in hMSH2-deficient tumor cell lines
32. Emergence of genetic instability in children treated for leukemia
33. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood
34. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans
35. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria
36. Acquired DNA mutations associated with in vivo hydroxyurea exposure
37. Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice
38. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome
39. Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria
40. A novel type of factor XI deficiency showing compound genetic abnormalities: A nonsense mutation and an impaired transcription
41. In vivo mutation at the human HPRT locus
42. The pathophysiology of acquired aplastic anemia
43. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes